Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
University of Wisconsin, Madison
Duke University
Aeterna Zentaris GmbH
Information provided by (Responsible Party):
Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT00776867
First received: October 20, 2008
Last updated: August 27, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2015
  Estimated Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)